SYSo-Young International Inc. exhibits mixed signals. While there are some positive fundamental indicators like revenue growth and a strong cash position, the company has been unprofitable recently. Technicals suggest a downtrend, and thematic factors related to its specific market niche need careful consideration. It is currently trading at a price point that reflects significant past growth, but its future trajectory is uncertain.
So-Young operates in the consumption healthcare and medical aesthetics market in China. This sector can be influenced by consumer spending, regulatory changes, and evolving trends in beauty and wellness. While there's potential for growth, it's a niche market with specific demographic and economic dependencies.
So-Young demonstrates strong revenue growth in its latest reported periods, supported by a healthy balance sheet with significant cash equivalents. However, the company is currently unprofitable, with negative net income and EPS. The valuation metrics are mixed, with a negative P/E ratio due to unprofitability, but a positive Price-to-Sales ratio.
The stock's current price (4.58) is near its 52-week low (0.664) but significantly below its 52-week high (6.28). Performance metrics show a strong recent surge (6M: 450%, YTD: 477%, 1Y: 385%), which is contradicted by the current price drop of -3.17%. Technical indicators across various timeframes (1m to 1d) largely suggest 'Sell' or 'Neutral' for moving averages and oscillators, indicating a potential downtrend or consolidation.
| Factor | Score |
|---|---|
| Medical Aesthetics Market Growth | 70 |
| Online Platform Dominance | 60 |
| Consumer Spending Sensitivity | 40 |
| Regulatory Landscape in China | 45 |
| Competition from other platforms/providers | 50 |
| Factor | Score |
|---|---|
| Valuation | 65 |
| Profitability | 20 |
| Growth | 40 |
| Balance Sheet Health | 85 |
| Cash Flow | 30 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 55 |
| Volume Trends | 50 |
| Support and Resistance | 50 |
| Short-term Oscillators | 45 |
Exceptional Short-Term Performance
The stock has experienced significant positive performance over shorter periods, with a 1-month return of 93.25% and a Year-to-Date (YTD) return of 477.67%, indicating strong recent investor interest and potential momentum.
Substantial Market Capitalization and Liquidity
The company has a market capitalization of $459.01 million and an average daily trading volume of 2.96 million shares, suggesting good liquidity and a sizable presence in the market.
Recent Price Decline
The stock price has recently decreased by 3.17% to $4.58, and the daily range indicates volatility, with the current price below the 52-week high.
Negative Earnings Per Share (EPS) and Net Income
The company has consistently reported negative EPS (e.g., -0.81 TTM) and negative net income (e.g., -$589.53 million in 2024), indicating a lack of profitability.
April 2025
8
Ex-Dividend Date
April 2025
25
Next Dividend Date
August 2025
21
Next Earnings Date
H: $-0.11
A: $-0.11
L: $-0.11
H: 362.23M
A: 362.23M
L: 362.23M
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive and minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems, and hydrodynamic-assisted liposuction systems, as well as pneumatic liquid spray devices. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Chaoyang, China.
5.71 USD
The 39 analysts offering 1 year price forecasts for SY have a max estimate of 10.11 and a min estimate of 1.51.